179 related articles for article (PubMed ID: 9626903)
1. Preventive effects of angiotensin-converting enzyme inhibitors on nitrate tolerance during continuous transdermal application of nitroglycerin in patients with chronic heart failure.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
Jpn Circ J; 1998 May; 62(5):353-8. PubMed ID: 9626903
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and rebound phenomenon related to intermittent nitroglycerin therapy for the prevention of nitrate tolerance.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
Jpn Circ J; 1998 Aug; 62(8):571-5. PubMed ID: 9741733
[TBL] [Abstract][Full Text] [Related]
3. Randomized, double-blind, placebo-controlled study of carvedilol on the prevention of nitrate tolerance in patients with chronic heart failure.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
J Am Coll Cardiol; 1998 Nov; 32(5):1194-200. PubMed ID: 9809925
[TBL] [Abstract][Full Text] [Related]
4. Preventive effects of carvedilol on nitrate tolerance--a randomized, double-blind, placebo-controlled comparative study between carvedilol and arotinolol.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
J Am Coll Cardiol; 1998 Nov; 32(5):1201-6. PubMed ID: 9809926
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind, placebo-controlled study of supplemental vitamin E on attenuation of the development of nitrate tolerance.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
Circulation; 1997 Oct; 96(8):2545-50. PubMed ID: 9355892
[TBL] [Abstract][Full Text] [Related]
6. Effects of enalapril during continuous nitrate therapy: analysis of diameter of coronary arteries and platelet cyclic guanosine monophosphate.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
Am Heart J; 1997 Oct; 134(4):614-21. PubMed ID: 9351727
[TBL] [Abstract][Full Text] [Related]
7. Long-term nitroglycerin treatment is associated with supersensitivity to vasoconstrictors in men with stable coronary artery disease: prevention by concomitant treatment with captopril.
Heitzer T; Just H; Brockhoff C; Meinertz T; Olschewski M; Münzel T
J Am Coll Cardiol; 1998 Jan; 31(1):83-8. PubMed ID: 9426022
[TBL] [Abstract][Full Text] [Related]
8. Influence of captopril on nitroglycerin-mediated vasodilation and development of nitrate tolerance in arterial and venous circulation.
Pizzulli L; Hagendorff A; Zirbes M; Fehske W; Ewig S; Jung W; Lüderitz B
Am Heart J; 1996 Feb; 131(2):342-9. PubMed ID: 8579031
[TBL] [Abstract][Full Text] [Related]
9. Prevention of nitrate tolerance with angiotension converting enzyme inhibitors.
Katz RJ; Levy WS; Buff L; Wasserman AG
Circulation; 1991 Apr; 83(4):1271-7. PubMed ID: 1901528
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, placebo-controlled study of the preventive effect of supplemental oral vitamin C on attenuation of development of nitrate tolerance.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
J Am Coll Cardiol; 1998 May; 31(6):1323-9. PubMed ID: 9581727
[TBL] [Abstract][Full Text] [Related]
11. [Randomized, double-blind, placebo-controlled study of supplemental vitamin E on attenuation of the development of nitrate tolerance].
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
J Cardiol; 1998 Mar; 31(3):173-81. PubMed ID: 9557281
[TBL] [Abstract][Full Text] [Related]
12. Effect of therapy with an angiotensin-converting enzyme inhibitor on hemodynamic and counterregulatory responses during continuous therapy with nitroglycerin.
Parker JD; Parker JO
J Am Coll Cardiol; 1993 May; 21(6):1445-53. PubMed ID: 8473654
[TBL] [Abstract][Full Text] [Related]
13. Platelet cyclic GMP. A potentially useful indicator to evaluate the effects of nitroglycerin and nitrate tolerance.
Watanabe H; Kakihana M; Ohtsuka S; Enomoto T; Yasui K; Sugishita Y
Circulation; 1993 Jul; 88(1):29-36. PubMed ID: 8391401
[TBL] [Abstract][Full Text] [Related]
14. Comparison of hemodynamic effects and plasma cyclic guanosine monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure.
Tsutamoto T; Kinoshita M; Hisanaga T; Maeda Y; Maeda K; Wada A; Fukai D; Yoshida S
Am J Cardiol; 1995 Jun; 75(16):1162-5. PubMed ID: 7762505
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, placebo-controlled study to evaluate the effect of organic nitrates in patients with chronic heart failure treated with angiotensin-converting enzyme inhibition.
Elkayam U; Johnson JV; Shotan A; Bokhari S; Solodky A; Canetti M; Wani OR; Karaalp IS
Circulation; 1999 May; 99(20):2652-7. PubMed ID: 10338458
[TBL] [Abstract][Full Text] [Related]
16. No cross-tolerance between S-nitrosocaptopril and nitroglycerin in dog coronary arteries in vivo.
Takaoka A; Nakae I; Takahashi M; Matsumoto T; Liu Q; Mitsunami K; Kinoshita M
J Cardiovasc Pharmacol; 1998 Feb; 31(2):231-9. PubMed ID: 9475264
[TBL] [Abstract][Full Text] [Related]
17. The effect of hydralazine on the development of tolerance to continuous nitroglycerin.
Parker JD; Parker AB; Farrell B; Parker JO
J Pharmacol Exp Ther; 1997 Feb; 280(2):866-75. PubMed ID: 9023301
[TBL] [Abstract][Full Text] [Related]
18. Effects of a new angiotensin-converting enzyme inhibitor, alacepril, on changes in neurohormonal factors and arterial baroreflex sensitivity in patients with congestive heart failure.
Kinugawa T; Kato M; Mori M; Endo A; Kato T; Hamada T; Noguchi N; Omodani H; Osaki S; Ogino K; Miyakoda H; Hisatome I; Shigemasa C
Eur J Clin Pharmacol; 1998 May; 54(3):209-14. PubMed ID: 9681661
[TBL] [Abstract][Full Text] [Related]
19. Effects of nitroglycerin ointment on plasma norepinephrine and cyclic nucleotides in congestive heart failure.
Ogasawara B; Ogawa K; Sassa H
J Cardiovasc Pharmacol; 1981; 3(4):867-75. PubMed ID: 6167816
[TBL] [Abstract][Full Text] [Related]
20. Counterregulatory responses: sustained-release isosorbide-5-mononitrate versus transdermal nitroglycerin.
Parker JD
J Cardiovasc Pharmacol; 1996 Nov; 28(5):631-8. PubMed ID: 8945675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
